A two part, open label, phase I single and repeat Investigational Product application study in healthy volunteeers, to determine the pharmacokinetic, safety and tolerability profiles of oxycodone delivered from a transdermal TPM/O patch.

Trial Profile

A two part, open label, phase I single and repeat Investigational Product application study in healthy volunteeers, to determine the pharmacokinetic, safety and tolerability profiles of oxycodone delivered from a transdermal TPM/O patch.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 06 Mar 2012 New source identified and integrated (Australia New Zealand Clinical Trials Registry)
    • 15 Feb 2012 Phosphagenics will undertake minor patch formulation changes before progressing into the multiple-dose part of the trial.
    • 15 Feb 2012 Results from the single-dose part of the trial reported in a Phosphagenics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top